{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T20:11:13Z","timestamp":1760645473658},"reference-count":16,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.leukres.2007.11.023","type":"journal-article","created":{"date-parts":[[2008,1,7]],"date-time":"2008-01-07T07:17:33Z","timestamp":1199690253000},"page":"936-943","source":"Crossref","is-referenced-by-count":15,"title":["An immunological method for the detection of BCR-ABL fusion protein and monitoring its activation"],"prefix":"10.1016","volume":"32","author":[{"given":"Iman","family":"Jilani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hagop","family":"Kantarjian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Homan","family":"Faraji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mercedes","family":"Gorre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Cortes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Ottmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kapil","family":"Bhalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis","family":"Giles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maher","family":"Albitar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2007.11.023_bib1","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1056\/NEJMoa011573","article-title":"Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia","volume":"346","author":"Kantarjian","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.leukres.2007.11.023_bib2","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1056\/NEJMoa022457","article-title":"Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia","volume":"348","author":"O\u2019Brien","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.leukres.2007.11.023_bib3","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1182\/blood-2004-08-3097","article-title":"The development of imatinib as a therapeutic agent for chronic myeloid leukemia","volume":"105","author":"Deininger","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2007.11.023_bib4","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/sj.leu.2403426","article-title":"Imatinib therapy in chronic myelogenous leukemia: strategies to avoid and overcome resistance","volume":"18","author":"Hochhaus","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2007.11.023_bib5","first-page":"534","article-title":"New tyrosine kinase inhibitors in chronic myeloid leukemia","volume":"90","author":"Martinelli","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2007.11.023_bib6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ccr.2005.01.020","article-title":"AMN107: tightening the grip of imatinib","volume":"7","author":"O\u2019Hare","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.leukres.2007.11.023_bib7","first-page":"160","article-title":"Quantitative polymerase chain reaction monitoring of BCR-ABL during therapy with imatinib mesylate (STI571; gleevec) in chronic-phase chronic myelogenous leukemia","volume":"9","author":"Kantarjian","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.leukres.2007.11.023_bib8","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1038\/sj.leu.2403157","article-title":"Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon alpha\/ara-C","volume":"17","author":"M\u00fcller","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2007.11.023_bib9","doi-asserted-by":"crossref","first-page":"35631","DOI":"10.1074\/jbc.M005401200","article-title":"c-Abl has high intrinsic tyrosine kinase activity that is stimulated by mutation of the Src homology 3 domain and by autophosphorylation at two distinct regulatory tyrosines","volume":"275","author":"Brasher","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.leukres.2007.11.023_bib10","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1073\/pnas.2436191100","article-title":"Profiling of tyrosine phosphorylation pathways in human cells using mass spectrometry","volume":"100","author":"Salomon","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.leukres.2007.11.023_bib11","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1365-2141.2004.04933.x","article-title":"Phosphatidylinositol-3 kinase inhibitors reproduce the selective antiproliferative effects of imatinib on chronic myeloid leukaemia progenitor cells","volume":"125","author":"Marley","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2007.11.023_bib12","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/cncr.20477","article-title":"Free circulating soluble CD52 as a tumor marker in chronic lymphocytic leukemia and its implication in therapy with anti-CD52 antibodies","volume":"101","author":"Albitar","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2007.11.023_bib13","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1182\/blood-2003-06-1840","article-title":"Relative increase in leukemia-specific DNA in peripheral blood plasma from patients with acute myeloid leukemia and myelodysplasia","volume":"103","author":"Rogers","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2007.11.023_bib14","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1002\/cncr.11416","article-title":"Results of imatinib mesylate therapy in patients with refractory or recurrent acute myeloid leukemia, high-risk myelodysplastic syndrome, and myeloproliferative disorders","volume":"97","author":"Cortes","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2007.11.023_bib15","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3324\/haematol.10360","article-title":"Plasma RNA as an alternative to cells for monitoring molecular response in patients with chronic myeloid leukemia","volume":"92","author":"Ma","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2007.11.023_bib16","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1200\/JCO.2004.03.050","article-title":"Pharmacokinetics and pharmacodynamics of imatinib in a phase I trial with chronic myeloid leukemia patients","volume":"22","author":"Peng","year":"2004","journal-title":"J Clin Oncol"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212607004584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212607004584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T17:51:47Z","timestamp":1546365107000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212607004584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S0145212607004584"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2007.11.023","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}